Literature DB >> 1707273

Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin.

M Haasemann1, P Nawratil, W Müller-Esterl.   

Abstract

Human alpha 2-HS glycoprotein and bovine fetuin, abundant proteins of fetal plasma, are structural members of the fetuin family within the cystatin superfamily. They are characterized by the presence of two N-terminally located cystatin-like units and a unique C-terminal sequence segment not present in the other members of the cystatin superfamily. Search for related sequences revealed that the natural inhibitor of the insulin receptor tyrosine kinase [Auberger, Falquerho, Contreres, Pages, Le Cam, Rossi & Le Cam (1989) Cell (Cambridge, Mass.) 58, 631-640] shows sequence similarity to the mammalian fetuins. The sequence identity between rat tyrosine kinase inhibitor, human alpha 2-HS glycoprotein and bovine fetuin is 56 and 60% respectively (percentage of residues in identical positions). The sequence similarity extends over the entire protein structures, except the extreme C-terminal portions. In particular, the number and relative positions of the cysteine residues are invariant among the proteins, suggesting that the characteristic array of linearly arranged and tandemly repeated disulphide loops of the cystatin superfamily is also present in rat tyrosine kinase inhibitor. We conclude that rat tyrosine kinase inhibitor may be classified as a novel member of the mammalian fetuin family.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707273      PMCID: PMC1149996          DOI: 10.1042/bj2740899

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  The covalent structure of individual N-linked glycopeptides from ovomucoid and asialofetuin.

Authors:  M G Yet; C C Chin; F Wold
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

2.  Human serum alpha 2HS-glycoprotein modulates in vitro bone resorption.

Authors:  G C Colclasure; W S Lloyd; M Lamkin; W Gonnerman; R F Troxler; G D Offner; W Bürgi; K Schmid; R B Nimberg
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

3.  Cystatin domains in alpha-2-HS-glycoprotein and fetuin.

Authors:  A Elzanowski; W C Barker; L T Hunt; E Seibel-Ross
Journal:  FEBS Lett       Date:  1988-01-25       Impact factor: 4.124

4.  Arrangement of the disulphide bridges in human low-Mr kininogen.

Authors:  J Kellermann; C Thelen; F Lottspeich; A Henschen; R Vogel; W Müller-Esterl
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

5.  A fetuin-related glycoprotein (alpha 2HS) in human embryonic and fetal development.

Authors:  K M Dziegielewska; K Møllgård; M L Reynolds; N R Saunders
Journal:  Cell Tissue Res       Date:  1987-04       Impact factor: 5.249

6.  Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions.

Authors:  R Vogel; I Assfalg-Machleidt; A Esterl; W Machleidt; W Müller-Esterl
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

7.  Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. Presence of two cystatin domains in the N-terminal region.

Authors:  T Koide; S Odani
Journal:  FEBS Lett       Date:  1987-05-25       Impact factor: 4.124

8.  The arrangement of disulfide loops in human alpha 2-HS glycoprotein. Similarity to the disulfide bridge structures of cystatins and kininogens.

Authors:  J Kellermann; H Haupt; E A Auerswald; W Müller-Ester
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

9.  Fetuin: the bovine homologue of human alpha 2HS glycoprotein.

Authors:  D L Christie; K M Dziegielewska; R M Hill; N R Saunders
Journal:  FEBS Lett       Date:  1987-04-06       Impact factor: 4.124

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  6 in total

1.  Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.

Authors:  Joachim H Ix; Michael G Shlipak; Vincent M Brandenburg; Sadia Ali; Markus Ketteler; Mary A Whooley
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

Review 2.  Anti-inflammatory role of fetuin-A in injury and infection.

Authors:  H Wang; A E Sama
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

3.  Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.

Authors:  Teruki Miyake; Masashi Hirooka; Osamu Yoshida; Shinya Furukawa; Teru Kumagi; Mitsuhito Koizumi; Shin Yamamoto; Taira Kuroda; Eiji Arimitsu; Eiji Takeshita; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2016-06-24       Impact factor: 7.527

4.  Fetuin-A and change in body composition in older persons.

Authors:  Joachim H Ix; Christina L Wassel; Glenn M Chertow; Annemarie Koster; Karen C Johnson; Frances A Tylavsky; Jane A Cauley; Steven R Cummings; Tamara B Harris; Michael G Shlipak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

5.  A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation.

Authors:  Wei Li; Shu Zhu; Jianhua Li; Yan Huang; Rongrong Zhou; Xuegong Fan; Huan Yang; Xing Gong; N Tony Eissa; Willi Jahnen-Dechent; Ping Wang; Kevin J Tracey; Andrew E Sama; Haichao Wang
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

6.  Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study.

Authors:  Teruki Miyake; Sakiko Yoshida; Shin Yamamoto; Shinya Furukawa; Osamu Yoshida; Sayaka Kanzaki; Hidenori Senba; Toru Ishihara; Mitsuhito Koizumi; Yoshio Tokumoto; Masashi Hirooka; Teru Kumagi; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.